JAZZ vs POOL · P/E 1988, rev $4.07B vs P/E 18, rev $5.31B
Jazz Pharmaceuticals PLC (JAZZ) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the JAZZ and POOL stock pages for the full models.
Not investment advice.